In 2023, Canada's re-import value of cortisone, hydrocortisone, prednisone, and prednisolone stood at $730.50. The forecast indicates a consistent decline in value from 2024 to 2028, dropping from $729.01 in 2024 to $722.52 in 2028. This represents a year-on-year percentage decrease, reflecting a steady but mild downtrend over the period. The compound annual growth rate (CAGR) over these five years underscores a slight negative growth trajectory in the import value.
Future trends to watch include potential shifts in demand due to healthcare policy changes, price fluctuations in global pharmaceutical markets, and advancements in alternative therapies that could impact import patterns.
